Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-491-7 | CAS number: 141-62-8
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation (Bacterial reverse mutation assay / Ames test): negative
with and without activation in all strains tested (OECD TG 471) (Wagner,
V. O., Hines, R. M., (2005)).
Cytogenicity in mammalian cells: read-across from structural analogue
octamethyltrisiloxane: negative in CHO cells (OECD TG 473) (Madraymootoo
and Rao (2008)).
Mutagenicity in mammalian cells: negative in L5178Y mouse lymphoma cells
(OECD TG 476) (Flanders, 2010).
The selected studies for bacterial and mammalian mutagenicity were the only studies available. They were conducted according to appropriate OECD guidelines and in compliance with GLP. The study selected for cytogenicity was the only available study for the surrogate substance. It was conducted according to an appropriate OECD guideline and in compliance with GLP.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005-09-15 to 2005-10-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor induced rat liver S9
- Test concentrations with justification for top dose:
- 50, 150, 500, 1500, 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Ethanol
- Justification for choice of solvent/vehicle: Solubility properties and relative non-toxicity to bacteria - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- All salmonella strains + WP2 uvrA (with activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA 98 (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA 100, TA 1535 (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA 1537 (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- WP2 uvrA (without activation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Expression time (cells in growth medium): 48 - 72 hours
NUMBER OF REPLICATIONS: 3 plates for each test concentration
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth; observation of background lawn density.
METABOLIC ACTIVATION: Aroclor induce rat liver S9; S9 mix included glucose-6-phophate and NADP as co-factors. 0.5ml of 10% S9 was added to 2 ml of top agar, 0.1 ml of tester strain and 0.05 ml of vehicle or test article giving a final concentration of approximately 2%.
- Evaluation criteria:
- A result is positive if the number of revertants is significantly increased compared with the solvent control to at least 2-fold of the solvent control for TA 98, TA 100 and WP2 uvrA and 3-fold of the solvent control for TA 1535 and TA 1537. There must be a dose related increase in the mean revertants per plate of at least one tester strain over a minimum of 2 increasing concentrations of test article.
Cytotoxicity is defined as a reduction in the number of colonies by >50% compared with the solvent control and/or at least a moderate reduction in
the background lawn (background code 3, 4 or 5). - Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Decamethyltetrasiloxane has been testing in a reliable study conducted according to OECD 471 1998 and under GLP up to limit concentrations. No increase in the number of revertants was observed at any concentration with and without metabolic activation in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and E. coli WP2 uvrA in either the initial plate incorporation assay or the independent repeat experiment which used the pre-incubation method. It is considered that the test substance was negative for mutagenicity to bacteria under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 August 2009 to 14 September 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital and beta-naphthoflavone-induced rat liver S9
- Test concentrations with justification for top dose:
- 12.5-200 µg/ml (4h) and 1.56-50 µg/ml (24h)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol;
- Justification for choice of solvent/vehicle: none given in study report - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without metabolic activation: 400 µg/ml (4 h exposure), 150 µg/ml (24 h exposure)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation: 2 µg/ml
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 h (with and without metabolic activation); 24 h (without metabolic activation)
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent): 10-14 days:
SELECTION AGENT (mutation assays): 5-trifluorothymidine
NUMBER OF REPLICATIONS: duplicate cultures
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth; other: % viability
OTHER EXAMINATIONS:
- Other: number of small and large colonies
OTHER: a preliminary toxicity assay was conducted up to a concentration of 3107 µg/ml (10 mM) - Evaluation criteria:
- For a test material to demonstrate a mutagenic response it must produce a reproducible and dose-dependent statistically significant increase in the induced mutant frequency (IMF) over the concurrent vehicle mutant frequency value, exceeding the Global Evaluation Factor (GEF) value of 126 E10-06.
- Statistics:
- UKEMS statistical package used.
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Changed to RTG 16% at 37.5 µg/ml (24h)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no marked change in pH was observed
- Effects of osmolality: did not increase by more than 50 mOsm
- Precipitation: a non-interfering precipitate of the test material observed at and above 100 μg/ml in the absence of metabolic activation, and at and above 150 μg/ml in the presence of metabolic activation.
- Other confounding effects: none
RANGE-FINDING/SCREENING STUDIES: No dose-related toxicity was observed following 4 h exposure; marked toxicity was observed in the 24 h exposure group.
COMPARISON WITH HISTORICAL CONTROL DATA: Control results were within the range of historical controls
CYTOTOXICITY: The toxicity observed in the main experiment differed from that in the preliminary cytotoxicity test. No explanation of this is given in the report. - Conclusions:
- Decamethyltetrasiloxane has been tested according to OECD TG 476 and under GLP conditions for mutagenicity to mouse lymphoma L5178Y cells up to cytotoxic concentrations. No increase in mutant frequency was detected at any concentration after 4h exposure with and without metabolic activation and 24 h exposure without metabolic activation. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of mutations in L5178Y cells under the conditions of the test.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008-10-07 - 2008-10-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Qualifier:
- according to guideline
- Guideline:
- other: EPA (TSCA) GLP 40 CFR Part 792
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: McCoy's 5A medium inc 10% FBS, 100 units penicillin/ml, 100 µg streptomycin/ml, 2mM L-glutamine
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes, cell stocks not used beyond passage 20 to ensure karyotype stability
- Periodically "cleansed" against high spontaneous background: no information - Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S9
- Test concentrations with justification for top dose:
- 4 hours (-MA): 2.5, 5, 12.5 µg/ml; 20 hours (-MA): 5, 10, 15 µg/ml; 4 hours (+MA): 10, 25 and 75 µg/ml.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Acetone
- Justification for choice of solvent/vehicle: none given in report - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- 4 hours without metabolic activation : 0.2 µg/ml
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- 4 hours with metabolic activation 10 µg/ml
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- 20 hours without metabolic activation : 0.1 µg/ml
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells): 24 hours
SPINDLE INHIBITOR (cytogenetic assays): Colcemid
STAIN (for cytogenetic assays): 5% Giemsa
NUMBER OF REPLICATIONS: duplicate cultures
NUMBER OF CELLS EVALUATED: 200 per dose level
DETERMINATION OF CYTOTOXICITY
- Method: cell growth inhibition
ACTIVATION:
Aroclor 1254-induced rat liver S9: S9 mix included glucose-6-phosphate and NADP as co-factors. - Evaluation criteria:
- The test article was considered to induce a positive response when the percentage of cells with aberrations was increased in a dose responsive manner with one or more concentrations being statistically significant (p<0.05). Values that are statistically significant but do not exceed the range of historical solvent controls may be judged as not biologically significant.
- Statistics:
- Fisher's Exact test and the Cochran-Armitage test to measure dose responsiveness.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Substantial cytotoxicity observed at dose levels > 23.4 µg/ml in all three treatment groups
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: pH of highest concentration approximately 7.5
- Effects of osmolality: considered acceptable, 2340 µg/ml was 281 mmol/kg, and did not exceed the osmolality of the solvent by more than 20%
- Precipitation: Visible precipitate in the form of oily droplets observed in treatment medium at 2340 µg/ml, dose levels < 702 µg/ml were soluble in treatment medium.
- Other confounding effects: none
RANGE-FINDING/SCREENING STUDIES:
COMPARISON WITH HISTORICAL CONTROL DATA: included in report
ADDITIONAL INFORMATION ON CYTOTOXICITY: - Conclusions:
- Octamethyltrisiloxane has been tested in a reliable in vitro cytogenetic assay according to OECD TG 473 and under GLP. The test substance did not induce statistically and biologically significant increases in the chromosomal aberration frequency in CHO cells. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of chromosome aberrations (is not clastogenic) in vitro under the conditions of the test.
Referenceopen allclose all
Table 2a: Toxicity and mutagenicity assay - plate incorporation (mean of 2 plates)
|
TA98 |
TA100 |
TA1535 |
||||||
Conc. |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
0* |
26 |
22 |
No |
161 |
145 |
No |
25 |
25 |
No |
1.5 |
23 |
24 |
No |
130 |
134 |
No |
26 |
20 |
No |
5 |
17 |
22 |
No |
126 |
152 |
No |
22 |
17 |
No |
15 |
15 |
25 |
No |
107 |
125 |
No |
16 |
23 |
No |
50 |
14 |
27 |
No |
108 |
128 |
No |
17 |
29 |
No |
150 |
17 |
24 |
No |
124 |
153 |
No |
24 |
18 |
No |
500 |
23 |
23 |
No |
133 |
148 |
No |
21 |
21 |
No |
1500 |
16 |
20 |
No |
115 |
129 |
No |
27 |
20 |
No |
5000 |
21 |
20 |
No |
135 |
128 |
No |
25 |
18 |
No |
Positive Control |
173 |
488 |
No |
557 |
565 |
No |
342 |
78 |
No |
*solvent control with ethanol
Table 2b: Toxicity and mutagenicity assay - plate incorporation (mean of 2 plates)
|
TA1537 |
WP2 uvrA |
||||
Conc. |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
0* |
11 |
9 |
No |
28 |
13 |
No |
1.5 |
8 |
8 |
No |
17 |
25 |
No |
5 |
8 |
8 |
No |
22 |
19 |
No |
15 |
7 |
8 |
No |
27 |
17 |
No |
50 |
6 |
5 |
No |
20 |
19 |
No |
150 |
7 |
8 |
No |
22 |
24 |
No |
500 |
7 |
7 |
No |
16 |
24 |
No |
1500 |
9 |
6 |
No |
18 |
17 |
No |
5000 |
8 |
10 |
No |
22 |
17 |
No |
Positive Control |
871 |
62 |
No |
141 |
203 |
No |
*solvent control with ethanol
Table 3: Experiment 2 - preincubation Number of revertants per plate (mean of 3 plates)
|
TA98 |
TA100 |
TA1535 |
||||||
Conc. |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
0* |
18 |
24 |
No |
84 |
84 |
No |
16 |
21 |
No |
50 |
15 |
19 |
No |
80 |
72 |
No |
17 |
20 |
No |
150 |
15 |
26 |
No |
51 |
97 |
No |
15 |
19 |
No |
500 |
17 |
21 |
No |
78 |
81 |
No |
19 |
24 |
No |
1500 |
23 |
25 |
No |
67 |
90 |
No |
17 |
24 |
No |
5000 |
15 |
24 |
No |
80 |
103 |
No |
20 |
21 |
No |
Positive control |
96 |
124 |
No |
283 |
279 |
No |
184 |
64 |
No |
*solvent control with ethanol
Table 3: Experiment 2 - preincubation Number of revertants per plate (mean of 3 plates)
|
TA1537 |
WP2 uvrA |
||||
Conc. |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
0* |
9 |
9 |
No |
25 |
20 |
No |
50 |
7 |
7 |
No |
18 |
26 |
No |
150 |
5 |
9 |
No |
23 |
21 |
No |
500 |
8 |
5 |
No |
20 |
16 |
No |
1500 |
7 |
3 |
No |
21 |
18 |
No |
5000 |
8 |
7 |
No |
20 |
17 |
No |
Positive control |
505 |
29 |
No |
124 |
104 |
No |
*solvent control with ethanol
Table 1 Preliminary toxicity test
Concentration (μg/ml)
|
% RSG (-S9) 4-Hour Exposure
|
% RSG (+S9) 4-Hour Exposure
|
% RSG (-S9) 24-Hour Exposure
|
0 |
100 |
100 |
100 |
12.14 |
74 |
96 |
72 |
24.27 |
90 |
96 |
26 |
48.55 |
83 |
84 |
0 |
97.09 |
100 |
68 |
0 |
194.19 |
95 |
82 |
1 |
388.38 |
94 |
102 |
1 |
776.75 |
108 |
98 |
1 |
1553.5 |
100 |
102 |
4 |
3107 |
97 |
82 |
39 |
%RSG= Relative Suspension Growth
Table 2 Summary of results from main experiment, 4 h exposure
Treatment (μg/ml)
|
4-Hours-S-9 |
Treatment (μg/ml)
|
4-Hours+S-9
|
||||
%RSG |
RTG |
MF |
%RSG |
RTG |
MF |
||
0 |
100 |
1.00 |
89.99 |
0 |
100 |
1.00 |
114.53 |
12.5 |
112 |
1.29 |
89.46 |
12.5 |
113 |
1.04 |
91.57 |
25 |
111 |
1.28 |
82.23 |
25 |
106 |
1.20 |
95.58 |
50 |
121 |
1.42 |
89.78 |
50 |
102 |
1.05 |
101.72 |
100 P |
110 |
1.28 |
79.77 |
100 |
105 |
1.09 |
93.79 |
150 P |
109 |
1.28 |
86.92 |
150 P |
104 |
1.10 |
88.74 |
200 P |
122 |
1.38 |
86.12 |
200 P |
106 |
1.17 |
98.22 |
Linear trend NS |
Linear trend NS |
||||||
Positive control |
94 |
0.81 |
710.52 |
2 |
65 |
0.29 |
935.61 |
P Precipitate observed at the end of the exposure period.
* Not plated for viability or 5-TFT resistance
%RSG = Relative Suspension Growth
RTG = Relative Total Growth
MF = 5-TFT resistant mutants/106 viable cells 2 days after treatment
Table 3 Summary of results from main experiment, 24 h exposure
Treatment (μg/ml)
|
24-Hours-S-9 |
||
%RSG |
RTG |
MF |
|
0 |
100 |
1.00 |
96.68 |
1.56 * |
109 |
|
|
3.13 |
102 |
0.95 |
108.38 |
6.25 |
101 |
1.29 |
76.85 |
12.5 |
104 |
1.21 |
113.47 |
18.75 |
89 |
1.02 |
93.93 |
25 |
59 |
0.69 |
89.82 |
37.5 |
16 |
0.14 |
141.03 |
50 * |
9 |
|
|
Linear trend NS |
|||
Positive control |
92 |
0.69 |
992.94 |
* Not plated for viability or 5-TFT resistance
%RSG = Relative Suspension Growth = [(dose SG x dose Day 0 Factor)/vehicle control SG] x 100
P(0) = number of negative wells/total wells plated
2 day viability %V = (-lnP(0) x 100)/number of cells/well
RCE = Relative Cloning Efficiency = (%V/mean solvent control %V)x100%
RTG = Relative Total Growth = (RCE x RSG)/100%
MF = 5-TFT resistant mutants/106 viable cells 2 days after treatment
Summary table of cytogenetic analysis of CHO cells in the absence and presence of metabolic activation
Treatment µg/ml |
S9 Activation |
Treatment time |
Mean mitotic index (500 cells) |
Metaphase cells scored |
Mean aberrations per cell |
Cells with aberrations |
|
Numerical (%) |
Structural (%) |
||||||
Solvent control |
- |
4 |
11.2 |
200 |
0.000 |
0.0 |
0.0 |
2.5 |
- |
4 |
9.9 |
200 |
0.005 |
0.0 |
0.5 |
5 |
- |
4 |
9.8 |
200 |
0.000 |
0.5 |
0.0 |
12.5 |
- |
4 |
9.3 |
200 |
0.000 |
0.0 |
0.0 |
Positive control |
- |
4 |
5.2 |
200 |
0.370 |
0.0 |
20.0 |
|
|
|
|
|
|
|
|
Solvent control |
+ |
4 |
10.9 |
200 |
0.005 |
0.5 |
0.5 |
10 |
+ |
4 |
10.5 |
200 |
0.000 |
0.5 |
0.0 |
20 |
+ |
4 |
10.4 |
200 |
0.000 |
0.0 |
0.0 |
75 |
+ |
4 |
10.4 |
200 |
0.000 |
0.5 |
0.0 |
Positive control |
+ |
4 |
3.3 |
200 |
0.350 |
1.5 |
18.0 |
|
|
|
|
|
|
|
|
Solvent control |
- |
20 |
10.9 |
200 |
0.000 |
0.0 |
0.0 |
5 |
- |
20 |
8.9 |
200 |
0.005 |
0.0 |
0.5 |
10 |
- |
20 |
8.9 |
200 |
0.005 |
0.5 |
0.5 |
15 |
- |
20 |
5.5 |
200 |
0.000 |
0.0 |
0.0 |
Positive control |
- |
20 |
7.0 |
200 |
0.300 |
1.0 |
18.0 |
|
|
|
|
|
|
|
|
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Data are available for decamethyltetrasiloxane (L4) from reliable studies on mutagenicity to bacterial and to mammalian cells. No data are available for cytogenicity to mammalian cells for the registered substance, however, a reliable study is available for the structural analogue, octamethyltrisiloxane (L3, CAS 107 -51 -7). Decamethyltetrasiloxane and octamethyltrisiloxane both hydrolyse slowly (measured), producing dimethylsilanediol and trimethylsilanol. Neither siloxanes nor silanediols/silanetriols are likely to contribute to genetic toxicity, and both registered and analogue substances have long hydrocarbon side-chains. It is therefore considered appropriate to read-across the in vitro mammalian cytogenicity study from octamethyltrisiloxane to the registered substance. Additional information is given in a supporting report (PFA (2013aa)) attached in Section 13 of the IUCLID 6 dossier.
L3 was selected as read-across substance because it has the same hydrolysis products as L4, and both substances hydrolyse slowly (see Section 4.1.1.1). Neither substance has any functional groups that are associated with genetic toxicity. The genetic toxicity data available for other substances from the analogue group are summarised in the Table below.
CAS |
Name |
Bacterial Mutagenicity |
In VitroMammalian Cytogenicity |
In VitroMammalian Mutagenicity |
In VivoGenotox |
107-46-0 |
Hexamethyldisiloxane |
Negative Shin-Etsu (1994) |
Negative Shin-Etsu (1995) |
Negative Litton Bionetics (1978a) |
Negative in chromosome aberration assay Dow Corning Corporation (1982)
|
107-51-7 |
Octamethyltrisiloxane |
Negative Wagner, V. O. (2008) |
Negative Madraymootoo, W. and Rao, M. (2008) |
No data |
No data |
141-62-8 |
Decamethyltetrasiloxane |
Negative Wagner, V. O., Hines, R. M,. (2005) |
No data |
Negative Flanders L (2010) |
No data |
141-63-9 |
Dodecamethylpentasiloxane |
No data |
Awaiting results; 3rd experiment planned |
Awaiting results or waiver |
Proposal of in vivo micronucleus study may be required depending on result of in vitro tests |
Decamethyltetrasiloxane has been testing in a reliable study conducted according to OECD 471 1997 and under GLP up to limit concentrations (Wagner, V. O., Hines, R. M., (2005)). No increase in the number of revertants was observed at any concentration with and without metabolic activation in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and E. coli WP2 uvrA in either the initial plate incorporation assay or the independent repeat experiment which used the pre-incubation method. It is considered that the test substance was negative for mutagenicity to bacteria under the conditions of the test.
No information is available for the registered substance on the potential for clastogenicity to mammalian cells, but information is available for the structural analogue, octamethyltrisiloxane, from a reliable in vitro cytogenetic assay conducted according to OECD TG 473 and under GLP (Madraymootoo and Rao (2008)). The test substance did not induce statistically and biologically significant increases in the chromosomal aberration frequency in CHO cells. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of chromosome aberrations in vitro (is not clastogenic) under the conditions of the test.
Decamethyltetrasiloxane has been tested according to OECD TG 476 and under GLP conditions for mutagenicity to mouse lymphoma L5178Y cells up to cytotoxic concentrations (Flanders L (2010)). No increase in mutant frequency was detected at any concentration after 4h exposure with and without metabolic activation and 24 h exposure without metabolic activation. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of mutations in L5178Y cells under the conditions of the test.
The results of all the in vitro studies are negative, so there is no justification for proposal of in vivo testing.
)
Justification for classification or non-classification
Based on the available in vitro and in vivo genotoxicity data, decamethyltrisiloxane is not classified for mutagenicity according to Regulation (EC)1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
